Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Lifco Ab ( ($SE:LIFCO.B) ) has shared an announcement.
Lifco AB has announced the acquisition of a majority stake in Citodent Imaging B.V., a Dutch company specializing in software for managing X-ray and diagnostic imaging for dentists in Europe. The acquisition, which will be integrated into Lifco’s Dental business area by the third quarter of 2025, is not expected to significantly impact Lifco’s earnings or financial position for the current financial year.
The most recent analyst rating on ($SE:LIFCO.B) stock is a Hold with a SEK365.00 price target. To see the full list of analyst forecasts on Lifco Ab stock, see the SE:LIFCO.B Stock Forecast page.
More about Lifco Ab
Lifco is a company that provides a stable environment for small and medium-sized businesses, focusing on acquiring and developing niche market leaders that offer sustainable earnings growth and strong cash flows. The company operates in three business areas: Dental, Demolition & Tools, and Systems Solutions, and is known for its decentralized organizational structure. As of the end of 2024, Lifco comprised 257 operating companies across 34 countries, with significant financial performance reflected in an EBITA of SEK 5.9 billion and net sales of SEK 26.1 billion.
Average Trading Volume: 308,143
Technical Sentiment Signal: Buy
Current Market Cap: SEK150.4B
For detailed information about LIFCO.B stock, go to TipRanks’ Stock Analysis page.